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INTRODUCTION
Bacterial infection special gastrointestinal bacteria such as Brucella melitensis (B. melitensis) and Escherichia coli (E. coli) are one of important concerns in digestion system, immune functions, and general health in the worldwide people. B. melitensis is an aerobic Gram negative coccobacillus bacterium from the Brucellaceae family and it is the most virulent Brucella spp. that is the causative agents of brucellosis in both humans and animals special in sheep and goats. This bacterium is facultative intracellular pathogens with short rods shape and contains three biovars (biovars 1, 2 and 3). In infected sheep and goats the symptoms are abortions, stillbirths, and the birth of weak offspring (DELVECCHIO et al., 2002) . B. melitensis is a significant problem in under-developing countries and this pathogen is prevalent in southern and eastern edges of Mediterranean basin, particularly in Libya, Egypt, Tunisia, Syria, and in the Arabian Peninsula and Iran. The distribution of B. melitensis in Iran is varying in different areas of the country and biovar 1 is responsible for the disease in Isfahan, Khorasan, Guilan (north), Khoozestan (south), Yazd (central), and Kermanshah (west) provinces, whereas in Tehran and Azarbaijan the biovars 1, 2 and 3 are the responsible ones (ZOWGHI et al., 2008) . The 39-kilodalton protein (P39) is immunodominant protein and have important role in Brucella family infections (TIBOR et al., 1998) . The p39 gene antigen of B. melitensis encoding periplasmic binding protein (PBP) and combined with CpG motifs as an adjuvant has been shown to elicit a Th1-type immune response (AL-MARIRI et al., 2001; BHATTACHARJEE et al., 2006) . Shiga-like toxin 1 (stx1) and Shiga-like toxin 2 (stx2), also known as verotoxins produced by enterohemorrhagic E. coli (EHEC) and Shiga-like toxin-producing E. coli (STEC) such as E. coli O157:H7. These zoonotic food-borne pathogens are commonly associated with gastroenteritis, abdominal cramps and diarrhea which can be bloody, hemorrhagic colitis (HC), haemolytic-uremic syndrome (HUS) and in some cases death can occur. Stx genes in Shigella dysenteriae are located on the chromosome but these genes in E. coli are carried by lysogenic bacteriophages and can be acquired by horizontal gene transfer (O'BRIEN et al., 1992; MAURO and KOUDELKA, 2011) . EHEC infections caused by E. coli O157 as well as non-O157 strains have global distribution but in Iran have varying rates in different years and studied groups (SALMANZADEH-AHRABI et al., 2005; ALIKHANI et al., 2007; BONYADIAN et al., 2010; JAFARI et al., 2012) . Shiga toxins consist of two subunits include single A and B subunits. The B subunit of Stx1 and Stx2 binds to Gb3, which has been identified as the receptor for the Stx family (TAHAMTAN et al., 2010; SHARIFI-YAZDI et al., 2011; DOOSTI et al., 2011) . The B subunit pentamer binds to globotriaosyl ceramide receptors on the cell membrane while A subunit acts as an RNA N-glycosidase enzyme, that catalyzes the release of an adenine at position 4324 in 28S rRNA of eukaryotic cells and inhibits protein synthesis. Furthermore, A and B subunits of stx1 and stx2 in their nucleotide sequences and amino acid showed 57 to 60% and 55 to 57% homology, respectively (SATO et al., 2003; DOOSTI et al., 2011) .
In recent years, many vaccines are invented against bacterial pathogens like DNA vaccine. DNA vaccine is a kind of vaccines that induces immune responses by injecting it with genetically engineered DNA and could immunization against diseases caused by various pathogens such as bacteria, viruses, protozoa, and even use for tumors and illnesses with genetic origins (LUO et al., 2006; SUN et al., 2012) . DNA vaccines have many advantages include posing no risk of infection, induction of a long-lived immune response, elicit both humoral and cell mediated immunity, better stability than live attenuated vaccines, not required refrigeration, easy preparation, and cheap. The limitations of DNA vaccine are low but this type of vaccination would be restricted to pathogens with a distinctive protein immunogen, extended immunostimulation leads to chronic inflammation, and may increase slight risk of potentially disrupting normal cellular processes (LUO et al., 2006; SUN et al., 2012) . For production of DNA vaccine virulence factors such as p39 and stx2 genes in B. melitensis and E. coli, respectively could be selected and these genes are important in pathogenicity and immune responses of these bacteria (DHANASHREE and SHRIKAR MALLYA, 2008; SUN et al., 2012) . So, the present study was performed to generate of divalent DNA vaccine based on stx2 and p39 genes of E. coli and B. melitensis, respectively by cloning of these genes into expression vector pEEF1D-FLAG (pcDNA 3.1+).
MATERIALS AND METHODS

Bacterial culture and plasmid preparation
EHEC E. coli ATCC 3081 and smooth virulent B. melitensis strain M5 were maintained as frozen glycerol stocks were obtained from the Razi Institute (Karaj, Iran) and Microbiology laboratory of Islamic Azad University of Shahrekord Branch, respectively. B. melitensis were cultured into Brucella agar (Becton Dickinson Microbiological Systems, Franklin Lakes, NJ, USA) and E. coli ATCC 3081 were cultured on MacConkey agar and were incubated at 37°C in a 5% CO 2 atmosphere until OD 600 reaches 0.9-1. Also, pGEM-T easy vector and pcDNA 3.1 + (both Invitrogen, San Diego, CA) were used as cloning and expression vectors, respectively. E. coli strain Top10F' (Invitrogen, Carlsbad, USA) were cultured in 5 mL of Luria-Bertani (LB) broth at 37°C overnight and were used for cloning and plasmid preparation.
Bacterial DNA extraction
Bacterial genomic DNA was extracted from colonies of E. coli and B. melitensis using DNP TM Kit (CinnaGen, Iran) according to the manufacturer's recommendation. The quality of total extracted DNA was measured by NanoDrop ND-1000 (PeqLab) at a wavelength of 260/280 nm according to the method described by Sambrook and Russell (SAMBROOK and RUSSELL, 2001) .
Gene amplification
In the present study for amplification of stx2 and p39 genes specific oligonucleotide primers were designed according to the published sequences. The sequences of these primers included Stx2-F: 5'-ACGAAGCTTATGAAGAAGATGTTTATGGC-3' and Stx2-R: 5'-ACGCTCGAGGTCATTATTAAACTGCAC-3' (accession number: KJ158456.1) containing HindIII and XhoI restriction sites, respectively and P39-F: 5'-TAGTCTAGACGCCTGTTGCCAATGC-3' and P39-R: 5'-GCGCTCGAGTTATTTTGCGGCTTCAAC-3' (accession number: JF918761.1) containing XbaI and XhoI restriction sites, respectively. For genes amplification the polymerase chain reaction (PCR) was performed using Thermal Cycler (Mastercycler Gradient, Eppendrof, Germany) in a final reaction volume of 50 µL in 0.5 mL tubes containing 1 µg of DNA sample, 1 µM of each forward and reverse primers, 2 mM MgCl 2 , 200 mM dNTPs, 5 µL of 10X PCR buffer, and 1 unit of Taq DNA polymerase (all Fermentas, Germany). PCR temperature conditions involved an initial denaturation at 95°C for 5 minutes, followed by 32 cycles; denaturation at 94˚C for 1 min, annealing at 60˚C for 1 min, extension at 72˚C for 1 min, and a final extension at 72°C for 5 min was carried out at the end of the amplification program. The amplified products were detected in 2% agarose gel electrophoresis and the gel was stained with ethidium bromide and photograph was obtained under UVIdoc gel documentation systems (Uvitec, UK).
Cloning of stx and p39 genes and plasmid construction
The amplified genes were purified from the gel using QIAquick Gel Extraction Kit (Qiagen, Inc.) according to manufacturer's protocol. The extracted amplified products were T/A cloned in pGEM-T easy vector (Invitrogen, San Diego, CA) and the recombinant vectors were transformed into E. coli TOP10F' competent cells using calcium chloride solution and under heat shock (42°C) for 90s. Then, competent cells were cultured in LB agar media (Merck Co., Germany) containing Ampicillin antibiotic (100 µg/mL), IPTG (0.1 M) and Xgal (20 mg/mL) for screening of recombinant vectors at 37°C overnight. The white colonies were selected to preparation of matrix and were cultured again at 37°C overnight in LB broth media (containing Ampicillin antibiotic). The recombinant vectors were extracted from bacterial cells using Plasmid Mini Extraction Kit (BIONEER, South Korea) using manufacturer's instructions and PCR and restriction enzymes analysis were used for confirmation of cloning.
Sub-cloning of stx and p39 genes into expression vector pcDNA 3.1 +
The 285 and 1220 bp fragments of stx2 and p39 genes were removed from recombinant pGEM-T easy vectors (pGEM-T-stx2 and pGEM-T-p39) by HindIII-XhoI and XbaI-XhoI double digestion, respectively and were sub-cloned in linearized pcDNA 3.1 + expression vector (5428 bp) by these enzymes to produce pcDNA 3.1 + -stx2 and pcDNA 3.1 + -p39, respectively. Then, each recombinant linearized pcDNA 3.1 + using T4 ligase enzyme was ligated to generate the final recombinant expression vector (pcDNA 3.1 + -stx2-p39). This construct was confirmed by PCR using specific oligonucleotide primers for stx2 and p39 genes and HindIII and XbaI restriction enzymes digestion.
RESULTS
The amplified stx2 and p39 genes on 2% agarose gel were revealed 285 and 1220 bp, fragments, respectively (Figure 1 ). These genes were T/A cloned using HindIII-XhoI and XbaIXhoI double digestion into pGEM-T easy vector (3015 bp) and pGEM-T-stx2 and pGEM-T-p39 were produced, successfully. For confirmation of gene cloning pGEM-T-stx2 and pGEM-T-p39 recombinant vectors were digested by HindIII, XhoI, and XhoI restriction enzymes. Then, pGEM-T-stx2, pGEM-T-p39, and expression vector were digested and linearized with above restriction enzymes and stx2 and p39 genes were sub-cloned into pcDNA 3.1 + using T4 ligase enzyme and finally pcDNA 3.1 + -stx2-p39 recombinant expression construct were generated, successfully. The results of enzyme digestion of pcDNA 3.1 + -stx2-p39 construct on 2% agarose gel electrophoresis were revealed 1505 and 5428 bp for stx2-p39 consolidated segment and pcDNA 3.1 + vector (without inserted gene), respectively (Figure 2) . 
DISCUSSION
In recent years, generations of new vaccines to prevent bacterial pathogens are developed. In this study, a novel recombinant pcDNA 3.1 + -stx2-p39 expression vector was generated as a divalent DNA vaccine candidate. In order to achieve this goal first stx2 and p39 genes of E. coli and B. melitensis, respectively were amplified using specific oligonucleotide primers and were cloned successfully in pGEM-T easy vector. Then pGEM-T-stx2 and pGEM-Tp39 recombinant plasmids using HindIII, XhoI and XbaI restriction enzymes and T4 ligase enzyme were sub-cloned in linearized pcDNA 3.1 + expression vector, successfully and pCDNA3-stx2-p39 construct were generated. In recent decades, many studies performed to produce DNA vaccines and their applications against bacterial pathogens. KALUS et al. (1999) are used combination vaccinia vaccines and dual-gene vaccinia vaccines to enhance antigen-specific T-cell immunity via T-cell costimulation and indicated that direct bearing on the design of vaccine clinical trials for infectious agents and/or tumor associated antigens (KALUS et al., 1999) . AL-MARIRI et al. (2001) evaluated the potential of P39 recombinant proteins and BFR with CpG ODN as adjuvant in inducing a Th1 response and the efficiency of these vaccines to protect BALB/c mice against an infectious B. abortus evaluated and concluded that mice protected at 8 weeks but after BFR vaccination protection not observed. Their study showed that p39 factor that used in this study could stimulate the immune system as vaccine. LUO et al. (2006) constructed a DNA vaccine pcDNA3.1-Omp16 to investigate the potentiality of an Omp16-based DNA vaccine in protection against Brucella infection and concluded that Brucella DNA vaccine can elicit a higher cellular immune response and provide great protection for the host against Brucella infection. Their method same to the present work but we used stx2 and p39 genes of E. coli and B. melitensis to generate pCDNA3-stx2-p39 construct as a divalent DNA vaccine candidate. TU et al. (2015) in another study was cloned stx1 region (stx1a and stx1b) from E. coli O157:H7 into pET-32a with a single promoter, successfully, but in the present research, we cloned stx2 and p39 genes to pcDNA 3.1 + expression vector. CHATTOPADHYAY et al. (2003) were cloned and expressed stx2 gene of STEC E. coli O157:H7 to pUC 18 and pUC 19 vectors. MEHREN et al. (2000) in a pilot study evaluated the dual gene recombinant Avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas and showed it is associated with the induction of a CEA specific T-cell response. CAPOZZO et al. (2003) were cloned B subunit of stx2 to the pCDNA 3+ as a DNA vaccine against E. coli producing Hemolytic-Uremic Syndrome in a murine model. Moreover, ACHESON et al. (1995) were cloned B subunit of stx2 gene to the pET9 for expression and purification of this gene and in study of BENTANCOR et al. (2009) the A and B subunits of stx2 of E. coli were cloned to pGEM-T easy vector successful and their method and cloning vector same to the present work. DOOSTI et al. (2009) were evaluated the immunogenicity and the protective efficacy of a divalent fusion DNA vaccine encoding both the B. melitensis Omp31 protein and P39 protein and who designated pCDNA3 recombinant vector as a divalent DNA vaccine. Their study was showed that intramuscular injection of this divalent DNA vaccine based on the omp31 and p39 genes elicited cellular immune responses in Balb/c mice. In another study the heavy chain (HC) domain of Clostridium botulinum neurotoxin gene was cloned successful in E. coli using T/A cloning technique in PCR 8/GW/TOPO vector as a gene vaccine candidate (DOOSTI, 2013) . In addition, SUN et al. (2012) generated a divalent DNA vaccine based on Sia10 and OmpU and this vaccine induced cross protection against Streptococcus iniae and Vibrio anguillarum in Japanese flounder. DNA vaccines could activate both cellular and immune response to protect the host from the pathogens. To summarize, the recombinant pCDNA3-stx2-p39 DNA construct produced in the present study can be used as a DNA vaccine candidate against shiga-like toxin producing E. coli and virulence B. melitensis strains in future researches and the efficiency of this divalent DNA vaccine could evaluated in animal models.
